Scientific Articles   |    
Three-Year Changes in Bone Mineral Density Around the Knee After a Six-Month Course of Oral Alendronate Following Total Knee ArthroplastyA Prospective, Randomized Study
Ching-Jen Wang, MD1; Jun-Wen Wang, MD1; Jih-Yang Ko, MD1; Lin-Hsiu Weng, MD1; Chung-Cheng Huang, MD1
1 Departments of Orthopedic Surgery (C.-J.W., J.-W.W., J.-Y.K., and L.-H.W.) and Diagnostic Radiology (C.-C.H.), Chang Gung Memorial Hospital at Kaohsiung, 123 Ta-Pei Road, Niao-Sung Hsiang, Kaohsiung, Taiwan 833. E-mail address for C.-J. Wang: w281211@adm.cgmh.org.tw
View Disclosures and Other Information
In support of their research for or preparation of this manuscript, one or more of the authors received grants or outside funding from the National Science Council (NSC89-2314-13-182A-188) and Chang Gung Research Fund (CMRP-1026). None of the authors received payments or other benefits or a commitment or agreement to provide such benefits from a commercial entity. No commercial entity paid or directed, or agreed to pay or direct, any benefits to any research fund, foundation, educational institution, or other charitable or nonprofit organization with which the authors are affiliated or associated.
Investigation performed at the Departments of Orthopedic Surgery and Diagnostic Radiology, Chang Gung Memorial Hospital, Kaohsiung, Taiwan

The Journal of Bone and Joint Surgery, Incorporated
J Bone Joint Surg Am, 2006 Feb 01;88(2):267-272. doi: 10.2106/JBJS.E.00051
5 Recommendations (Recommend) | 3 Comments | Saved by 3 Users Save Case


Background: Bone mineral density decreases after total knee arthroplasty and is believed to affect prosthetic fixation. Treatment with alendronate has been shown to improve short-term bone mineral density after total knee arthroplasty; however, the long-term effects of this therapy are unknown. The purpose of this study was to evaluate the long-term effects of a six-month course of alendronate on bone mineral density after total knee arthroplasty.

Methods: Sixty patients were randomly assigned to receive either oral alendronate at a dosage of 10 mg/day for six months or no alendronate. The bone mineral density in the distal aspect of the femur and the proximal aspect of the tibia was measured preoperatively and at six, twelve, and thirty-six months after total knee arthroplasty.

Results: Fifty-four patients (twenty-nine in the alendronate group and twenty-five in the control group) completed the study. The alendronate group showed significant increases in bone mineral density in the distal aspect of the femur compared with the controls at six months (+4.8% and —14.2%, respectively; p < 0.01) and twelve months (+1.6% and —11.5%, respectively; p < 0.01). No significant difference in bone mineral density was detected between the groups at thirty-six months (—3.9% and —12.2%, respectively; p = 0.08). Similar trends in bone mineral density changes were also observed in the proximal aspect of the tibia.

Conclusions: A six-month course of alendronate initially increased bone mineral density at six and twelve months after total knee arthroplasty, but no difference was noted after thirty-six months. The effect of alendronate on bone mineral density after total knee arthroplasty may be limited after discontinuation of therapy.

Level of Evidence: Therapeutic Level I. See Instructions to Authors for a complete description of levels of evidence.

Figures in this Article
    Sign In to Your Personal ProfileSign In To Access Full Content
    Not a Subscriber?
    Get online access for 30 days for $35
    New to JBJS?
    Sign up for a full subscription to both the print and online editions
    Register for a FREE limited account to get full access to all CME activities, to comment on public articles, or to sign up for alerts.
    Register for a FREE limited account to get full access to all CME activities
    Have a subscription to the print edition?
    Current subscribers to The Journal of Bone & Joint Surgery in either the print or quarterly DVD formats receive free online access to JBJS.org.
    Forgot your password?
    Enter your username and email address. We'll send you a reminder to the email address on record.

    Forgot your username or need assistance? Please contact customer service at subs@jbjs.org. If your access is provided
    by your institution, please contact you librarian or administrator for username and password information. Institutional
    administrators, to reset your institution's master username or password, please contact subs@jbjs.org


    Accreditation Statement
    These activities have been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the American Academy of Orthopaedic Surgeons and The Journal of Bone and Joint Surgery, Inc. The American Academy of Orthopaedic Surgeons is accredited by the ACCME to provide continuing medical education for physicians.
    CME Activities Associated with This Article
    Submit a Comment
    Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
    Comments are moderated and will appear on the site at the discretion of JBJS editorial staff.

    * = Required Field
    (if multiple authors, separate names by comma)
    Example: John Doe

    Related Content
    The Journal of Bone & Joint Surgery
    JBJS Case Connector
    Topic Collections
    Related Audio and Videos
    PubMed Articles
    Osteoporosis/fracture prevention clinical practice guidelines. -Kaiser Permanente Care Management Institute | 10/2/2009
    Bone health. In: Menopause and osteoporosis update 2009. -Society of Obstetricians and Gynaecologists of Canada | 6/12/2009
    Results provided by:
    Clinical Trials
    Readers of This Also Read...
    JBJS Jobs
    NY - Modern Chiropractic Care, P.C.
    VA - OrthoVirginia
    SC - Department of Orthopaedic Surgery Medical Univerity of South Carlonina
    IL - Hinsdale Orthopaedics